Please wait a minute...
浙江大学学报(医学版)  2020, Vol. 49 Issue (3): 389-396    DOI: 10.3785/j.issn.1008-9292.2020.04.12
原著     
晚期妊娠孕妇B群链球菌定植状况及妊娠结局分析
杨林东1(),包芳1,2,吴元赭1,孙丽洲3,*()
1. 东部战区总医院妇产科, 江苏 南京 210002
2. 南京医科大学金陵临床医学院妇产科, 江苏 南京 210002
3. 南京医科大学第一附属医院妇产科, 江苏 南京 210029
Relationship of group B streptococcus colonization in late pregnancy with perinatal outcomes
YANG Lindong1(),BAO Fang1,2,WU Yuanzhe1,SUN Lizhou3,*()
1. Department of Obstetrics and Gynecology, General Hospital of PLA Eastern Theater Command, Nanjing 210002, China
2. Department of Obstetrics and Gynecology, Jinling Hospital, Nanjing Medical University, Nanjing 210002, China
3. Department of Obstetrics and Gynecology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
 全文: PDF(1091 KB)   HTML( 5 )
摘要:

目的: 探讨妊娠晚期孕妇B群链球菌(GBS)定植情况、抗菌药物敏感性及妊娠结局。方法: 纳入2016年1月至2018年12月在东部战区总医院和南京医科大学第一附属医院妇产科定期产检的孕妇,于孕35~37周采用标准方法采集阴道及直肠拭子进行GBS培养,并对阳性标本分离的菌株进行药物敏感性试验。按培养结果分为GBS阳性组和GBS阴性组,阳性组按照产程中是否使用了抗菌药物治疗分为用药组与未用药组,比较不同组别妊娠结局的差异。结果: 共13 000名孕妇入组,GBS总体定植率为3.65%(475/13 000)。GBS在阴道中定植率为2.33%(303/13 000),在直肠中定植率为1.75%(227/13 000)。通过对直肠标本的采集检测,GBS阳性检出率增加了56.77%(172/303)。GBS每月的定植率有明显波动,3月份和10月份最高(均P < 0.05)。475份GBS阳性标本对头孢曲松、万古霉素和利奈唑胺的敏感率为100%,对氨苄西林和青霉素的敏感率分别为97.26%和93.47%,而对左氧氟沙星、克林霉素、红霉素、四环素的耐药率较高,分别为30.11%、48.00%、52.21%和88.63%。GBS阳性组胎膜早破、产后出血、产褥期感染、新生儿肺炎、败血症发生率较GBS阴性组明显增高(均P < 0.01)。产程中预防性使用抗菌药物的GBS阳性孕妇产褥期感染、新生儿感染及新生儿重症监护室入住率明显低于未使用抗菌药物的孕妇(P < 0.05或P < 0.01)。结论: 妊娠晚期孕妇GBS定植率较低,无明显的季节性,通过补充直肠检测能提高GBS检出率。头孢曲松、氨苄西林和青霉素是目前预防和治疗GBS相关疾病的首选药物。GBS感染会明显增加母婴并发症的发生可能,产程中抗菌药物治疗可以改善母婴的结局。

关键词: 妊娠末期无乳链球菌抗菌药微生物敏感性试验妊娠结局围生医学阴道/微生物学直肠/微生物学    
Abstract:

Objective: To investigate the relationship of group B streptococcus (GBS) colonization in late pregnancy with perinatal outcome. Methods: Pregnant women who underwent antenatal check-up at General Hospital of PLA Eastern Theater Command and the First Affiliated Hospital of Nanjing Medical University from January 2016 to December 2018 were enrolled in the study. The vaginal and rectal swab samples were collected for GBS culture at 35-37 weeks of pregnancy. The perinatal outcomes of positive and negative GBS groups were compared. The GBS-positive group samples were tested for antibiotic susceptibility. In GBS positive group the maternal and child perinatal outcomes were compared between pregnant women with antibiotics treatment and those without antibiotics. Results: A total of 13 000 pregnant women were enrolled, and the overall colonization rate of GBS was 3.65%(475/13 000). The colonization rate of GBS in the vagina was 2.33%(303/13 000), and the colonization rate in the rectum was 1.75%(227/13 000). Through the collection and detection of rectal specimens, the positive rate of GBS increased by 56.77%(172/303). The monthly colonization rate of GBS showed significant fluctuations with the highest in March and October (all P < 0.05). The sensitivity of 475 GBS-positive specimens to ceftriaxone, vancomycin and linezolid were 100%, and the sensitivity to ampicillin and penicillin were 97.26%and 93.47%, respectively. The resistance rates of the strains to levofloxacin, clindamycin, erythromycin and tetracycline were 30.11%, 48.00%, 52.21%and 88.63%. The incidence of premature rupture of membranes, postpartum hemorrhage, puerperal infection, neonatal pneumonia and sepsis in GBS positive group were significantly higher than those in GBS negative group (all P < 0.01). In pregnant women with positive GBS, the incidence of puerperal infection, neonatal infection and admission to the NICU in the antibiotic group were significantly lower than those in the non-antibiotic group (P < 0.05 or P < 0.01). Conclusions: The total colonization rate of GBS is low. The detection of GBS can be significantly improved by supplementing rectal examination. Ceftriaxone, ampicillin and penicillin are currently the drugs of choice for the prevention and treatment of GBS-related diseases. GBS infection can increase the incidence of maternal and child complications. The use of antibiotics during labor can improve the outcome of mothers and infants.

Key words: Pregnancy trimester, third    Streptococcus agalactiae    Anti-bacterial agents    Microbial sensitivity tests    Pregnancy outcome    Perinatology    Vagina/microbiology    Rectum/microbiology
收稿日期: 2019-08-20 出版日期: 2020-04-16
CLC:  R714.1  
基金资助: 国家重点研发计划(2018YFC1004300)
通讯作者: 孙丽洲     E-mail: yanglingdong-123@163.com;lizhou_sun@163.com
作者简介: 杨林东(1983—), 男, 博士, 副主任医师, 主要从事妇产科临床研究; E-mail:yanglingdong-123@163.com; https://orcid.org/0000-0003-3315-5271
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  
杨林东
包芳
吴元赭
孙丽洲

引用本文:

杨林东,包芳,吴元赭,孙丽洲. 晚期妊娠孕妇B群链球菌定植状况及妊娠结局分析[J]. 浙江大学学报(医学版), 2020, 49(3): 389-396.

YANG Lindong,BAO Fang,WU Yuanzhe,SUN Lizhou. Relationship of group B streptococcus colonization in late pregnancy with perinatal outcomes. J Zhejiang Univ (Med Sci), 2020, 49(3): 389-396.

链接本文:

http://www.zjujournals.com/med/CN/10.3785/j.issn.1008-9292.2020.04.12        http://www.zjujournals.com/med/CN/Y2020/V49/I3/389

阴道直肠合计
阳性阴性
阳性55248303
阴性17212 52512 697
合计22712 77313 000
表 1  13 000名孕妇妊娠晚期阴道和直肠B群链球菌检测结果
图 1  2016—2018年不同月份B群链球菌(GBS)检出率比较
抗菌药物敏感中介耐药
头孢曲松475(100.00)0(0.00)0(0.00)
万古霉素475(100.00)0(0.00)0(0.00)
利奈唑胺475(100.00)0(0.00)0(0.00)
氨苄西林462(97.26)13(2.74)0(0.00)
青霉素444(93.47)31(6.53)0(0.00)
左氧氟沙星332(69.89)0(0.00)143(30.11)
克林霉素214(45.05)33(6.95)228(48.00)
红霉素181(38.11)46(9.68)248(52.21)
四环素54(11.37)0(0.00)421(88.63)
表 2  B群链球菌对常用抗菌药物的敏感性试验结果
组别n平均年龄(岁)年龄≥35岁流产史初产妇体质指数≥30 kg/m2
“—”:无相关数据.
GBS阳性组47530.3±4.079(16.63)313(65.89)220(46.32)76(16.00)
GBS阴性组12 52530.0±4.52289(18.28)8642(69.00)6262(50.00)2380(19.00)
t/χ21.7030.8302.0562.4792.692
P>0.05>0.05>0.05>0.05>0.05
表 3  B群链球菌(GBS)阳性与阴性孕妇一般资料比较
组别n剖宫产胎膜早破产后出血产褥期感染胎儿窘迫新生儿死亡*新生儿肺炎新生儿败血症入住NICU
“—”:无相关数据.*Fisher精确检验;#死于重度脓毒血症;Δ2例死于呼吸窘迫症,1例死于脓毒血症,1例死于重度肺部感染.NICU:新生儿重症监护室.
GBS阳性组475175(36.84)116(24.42)47(9.89)53(11.16)38(8.00)1(0.21)#8(1.68)10(2.11)34(7.16)
GBS阴性组12 5254384(35.00)2255(18.00)238(1.90)876(6.99)751(6.00)4(0.03)Δ50(0.40)37(0.30)1006(8.03)
t/χ20.68112.638136.40811.9583.22414.24436.7410.475
P>0.05<0.01<0.01<0.01>0.05>0.05<0.01<0.01>0.05
表 4  B群链球菌(GBS)阳性与阴性孕妇妊娠结局比较
组别n平均年龄(岁)年龄≥35岁流产史初产妇体质指数≥30 kg/m2产褥期感染新生儿感染入住NICU
“—”:无相关数据.NICU:新生儿重症监护室.
用药组15230.1±4.024(15.78)95(62.50)74(48.68)20(13.16)14(9.21)5(3.29)12(7.89)
未用药组32330.4±4.155(17.03)213(65.94)168(52.01)58(17.96)72(22.29)66(20.43)54(16.72)
t/χ2-0.6010.1140.5380.4581.73411.92723.8966.726
P>0.05>0.05>0.05>0.05>0.05<0.01<0.01<0.05
表 5  预防性用药和未用药的B群链球菌阳性孕妇一般资料和妊娠结局比较
1 EICKHOFF T C , KLEIN J O , DALY A K et al. Neonatal sepsis and other infections due to group B beta-hemolytic streptococci[J]. N Engl J Med, 1964, 271 1221- 1228
doi: 10.1056/NEJM196412102712401
2 LE DOARE K , HEATH P T . An overview of global GBS epidemiology[J]. Vaccine, 2013, 31 (Suppl 4): D7- D12
doi: 10.1016/j.vaccine.2013.01.009
3 EDMOND K M , KORTSALIOUDAKI C , SCOTT S et al. Group B streptococcal disease in infants aged younger than 3 months:systematic review and meta-analysis[J]. Lancet, 2012, 379 (9815): 547- 556
doi: 10.1016/S0140-6736(11)61651-6
4 VERANI J R , MCGEE L , SCHRAG S J et al. Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010[J]. MMWR Recomm Rep, 2010, 59 (RR-10): 1- 36
5 CHEN V L , AVCI F Y , KASPER D L . A maternal vaccine against group B streptococcus:past, present, and future[J]. Vaccine, 2013, 31 (Suppl 4): D13- D19
doi: 10.1016/j.vaccine.2012.12.080
6 Clinical and Laboratory Standards Institute. M100-S22 Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement[S]. Wayne, PA: Clinical and Laboratory Standards Institute, 2012.
7 JOHRI A K , LATA H , YADAV P et al. Epidemiology of group B streptococcus in developing countries[J]. Vaccine, 2013, 31 (Suppl 4): D43- D45
doi: 10.1016/j.vaccine.2013.05.094
8 KWATRA G , CUNNINGTON M C , MERRALL E et al. Prevalence of maternal colonisation with group B streptococcus:a systematic review and meta-analysis[J]. Lancet Infect Dis, 2016, 16 (9): 1076- 1084
doi: 10.1016/S1473-3099(16)30055-X
9 CHO C Y , TANG Y H , CHENY H et al. Group B Streptococcal infection in neonates and colonization in pregnant women:An epidemiological retrospective analysis[J]. J Microbiol Immunol Infect, 2019, 52 (2): 265- 272
doi: 10.1016/j.jmii.2017.08.004
10 LU B , LI D , CUI Y et al. Epidemiology of group B streptococcus isolated from pregnant women in Beijing, China[J]. Clin Microbiol Infect, 2014, 20 (6): O370- O373
doi: 10.1111/1469-0691.12416
11 JI W, ZHANG L, GUO Z, et al. Colonization prevalence and antibiotic susceptibility of group B streptococcus in pregnant women over a 6-year period in Dongguan, China[J/OL]. PLoS One, 2017, 12(8): e0183083. DOI: 10.1371/journal.pone.0183083.
12 时春艳, 曲首辉, 杨磊 et al. 妊娠晚期孕妇B族链球菌带菌状况的检测及带菌对妊娠结局的影响[J]. 中华妇产科杂志, 2010, 45 (1): 12- 16
SHI Chunyan , QU Shouhui , YANG Lei et al. Detection of maternal colonization of group B streptococcus in late pregnancy by real-time polymerase chain reaction and its effect on perinatal outcome[J]. Chinese Journal of Obstetrics and Gynecology, 2010, 45 (1): 12- 16
doi: 10.3760/cma.j.issn.0529-567x.2010.01.005
13 RICK A M , AGUILAR A , CORTES R et al. Group B streptococci colonization in pregnant guatemalan women:prevalence, risk factors, and vaginal microbiome[J]. Open Forum Infect Dis, 2017, 4 (1): ofx020
doi: 10.1093/ofid/ofx020
14 PHILIPSON E H , PALERMINO D A , ROBINSON A . Enhanced antenatal detection of group B streptococcus colonization[J]. Obstet Gynecol, 1995, 85 (3): 437- 439
doi: 10.1016/0029-7844(94)00412-7
15 KOVAVISARACH E , SA-ADYING W , KANJANAHAREUTAI S . Comparison of combined vaginal-anorectal, vaginal and anorectal cultures in detecting of group B streptococci in pregnant women in labor[J]. J Med Assoc Thai, 2007, 90 (9): 1710- 1714
16 MA Y Y , HSU T Y , SHEN S Y et al. Epidemiology of group B streptococcus ST-17 clone in pregnant women of South Taiwan[J]. Gynecol Obstet Invest, 2012, 73 (4): 285- 293
doi: 10.1159/000334406
17 林新祝, 吴健宁, 张雪芹 et al. 晚孕期阴道B族链球菌定植与新生儿感染的关系[J]. 中华围产医学杂志, 2016, 19 (7): 491- 496
LIN Xinzhu , WU Jianning , ZHANG Xueqin et al. Relationship between group B streptococcus colonization in late pregnancies and neonatal infection[J]. Chinese Journal of Perinatal Medicine, 2016, 19 (7): 491- 496
doi: 10.3760/cma.j.issn.1007-9408.2016.07.003
18 PHARES C R , LYNFIELD R , FARLEY M M et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005[J]. JAMA, 2008, 299 (17): 2056- 2065
doi: 10.1001/jama.299.17.2056
19 DE AZAVEDO J C , MCGAVIN M , DUNCANC et al. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada[J]. Antimicrob Agents Chemother, 2001, 45 (12): 3504- 3508
doi: 10.1128/AAC.45.12.3504-3508.2001
20 MORIKAWA Y , KITAZATO M , KATSUKAWA C et al. Prevalence of cefotaxime resistance in group B streptococcus isolates from Osaka, Japan[J]. J Infect Chemother, 2003, 9 (2): 131- 133
doi: 10.1007/s10156-002-0230-6
21 沈铿, 马丁, 狄文 et al. 妇产科学[M]. 3版, 北京: 人民卫生出版社, 2015: 164- 166
SHEN Keng , MA Ding , DI Wen et al. Obstetrics and gynecology[M]. 3rd ed, Beijing: People's Medical Publishing House, 2015: 164- 166
22 BARCAITE E , BARTUSEVICIUS A , TAMELIENE R et al. Prevalence of maternal group B streptococcal colonisation in European countries[J]. Acta Obstet Gynecol Scand, 2008, 87 (3): 260- 271
doi: 10.1080/00016340801908759
23 GHADDAR N , ALFOUZAN W , ANASTASIADIS E et al. Evaluation of chromogenic medium and direct latex agglutination test for detection of group B streptococcus in vaginal specimens from pregnant women in Lebanon and Kuwait[J]. J Med Microbiol, 2014, 63 (Pt 10): 1395- 1399
doi: 10.1099/jmm.0.066738-0
24 ARMISTEAD B , OLER E , ADAMS WALDORF K et al. The double life of group B streptococcus:asymptomatic colonizer and potent pathogen[J]. J Mol Biol, 2019, 431 (16): 2914- 2931
doi: 10.1016/j.jmb.2019.01.035
25 BAKER C J . The spectrum of perinatal group B streptococcal disease[J]. Vaccine, 2013, 31 (Suppl 4): D3- D6
doi: 10.1016/j.vaccine.2013.02.030
26 GARVY B A , HARMSEN A G . The importance of neutrophils in resistance to pneumococcal pneumonia in adult and neonatal mice[J]. Inflammation, 1996, 20 (5): 499- 512
doi: 10.1007/bf01487042
27 STOLL B J , HANSEN N I , SáNCHEZP J et al. Early onset neonatal sepsis:the burden of group B streptococcal and E. coli disease continues[J]. Pediatrics, 2011, 127 (5): 817- 826
doi: 10.1542/peds.2010-2217
28 邓江红, 姚开虎, 胡惠丽 et al. 新生儿肺炎死亡病例中B族链球菌的检测[J]. 中华儿科杂志, 2006, 44 (11): 850- 854
DENG Jianghong , YAO Kaihu , HU Huili et al. Detection of group B streptococcus in the cases died of neonatal pneumonia[J]. Chinese Journal of Pediatrics, 2006, 44 (11): 850- 854
doi: 10.3760/j.issn:0578-1310.2006.11.015
[1] 陈旭,李央,王金希,蔡洪流,曹红翠,盛吉芳. 三例妊娠合并2019冠状病毒病(COVID-19)患者诊治分析[J]. 浙江大学学报(医学版), 2020, 49(2): 240-244.
[2] 林啸笑,孙待飞,傅君,钟惠珍. 子宫动脉栓塞术治疗产后出血对再次妊娠结局的影响[J]. 浙江大学学报(医学版), 2019, 48(5): 540-545.
[3] 梅瑾,刘姣,王敏,张闻,王昊,卢莎,何茶英,靳春雷. 八例22q11.2区微重复胎儿产前诊断和妊娠结局分析[J]. 浙江大学学报(医学版), 2019, 48(4): 429-433.
[4] 孙婷,徐明娟. 妊娠期正常高值血压产妇体质量及妊娠结局的回顾性分析[J]. 浙江大学学报(医学版), 2019, 48(2): 174-179.
[5] 史婧,冯钰. 细菌RNA聚合酶抑制剂的分子生物学机制研究进展[J]. 浙江大学学报(医学版), 2019, 48(1): 44-49.
[6] 彭丹丹,周旭东. 宁波市儿童家长抗菌药物知识、使用行为及其影响因素分析[J]. 浙江大学学报(医学版), 2018, 47(2): 156-162.
[7] 李恩书 等. 不同氧浓度培养对体外受精-胚胎移植及子代出生缺陷的影响[J]. 浙江大学学报(医学版), 2017, 46(3): 290-294.
[8] 石碧炜 等. 胚胎冻融对卵裂期行植入前遗传学诊断或筛查后可移植胚胎临床结局的影响[J]. 浙江大学学报(医学版), 2017, 46(3): 295-299.
[9] 张坚贞, 贺晶. 再发子痫前期相关因素及母子转归的单中心临床研究[J]. 浙江大学学报(医学版), 2015, 44(3): 258-263.
[10] 沈亲亲, 张檀. 产前筛查血清学指标与不良妊娠结局关系的研究进展[J]. 浙江大学学报(医学版), 2015, 44(3): 339-343.
[11] 张劼, 李秀娟. 嗜麦芽窄食单胞菌噬菌体SM1生物学特征及其在感染动物模型中的疗效[J]. 浙江大学学报(医学版), 2013, 42(3): 331-336.
[12] 李苗, 朱依敏. 乙型肝炎病毒对精子和辅助生殖技术结局的影响[J]. 浙江大学学报(医学版), 2013, 42(2): 237-241.
[13] . Alloferon-1抗生肽串联重组表达及重组Alloferon-1体外抗肿瘤活性[J]. 浙江大学学报(医学版), 2011, 40(5): 501-507.
[14] 张维,柳开忠. 不动杆菌对碳青霉烯类抗生素的耐药机制和治疗进展[J]. 浙江大学学报(医学版), 2010, 39(5): 542-547.
[15] 王倩倩;朱依敏;吴明远. 体外受精母亲与子代健康状况分析[J]. 浙江大学学报(医学版), 2009, 38(5): 515-520.